Matt Eggleston (Child and Adolescent Psychiatrist) explains the range of medications available for treating ADHD. He talks about short, medium and long acting forms of medication and different approaches to reflect age and other conditions.

Matt Eggleston (Child and Adolescent Psychiatrist) refers to a comprehensive trial that compared the medication approach and the psychosocial approach to treating ADHD and how this trial impacted on the way ADHD is treated.

Matt Eggleston (Child and Adolescent Psychiatrist) addresses parents’ concerns about their child becoming a Zombie. Matt notes that high dosage rates can impact on a child’s personality. A reduction in the rate leads to an immediate positive change – there is no permanent effect.

Matt Eggleston (Child and Adolescent Psychiatrist) notes that there is a lack of research on the benefits of natural remedies. He talks about Omega 3 and notes that it might have a mild impact. He also refers to the ongoing UoC micronutrient trial.

Matt Eggleston (Child and Adolescent Psychiatrist) talks about the impact of medication on growth. He explains that there is a negative impact on appetite for 20% to 30% of children and this can effect height and weight at adulthood. He also talks about the impact on behavior.